CLINICAL_TRIALS
withdrawal
· 2018-04-18
Clinical Trial Update: Efficacy of Using Solum IV and BMC With GFC in TLIF [Phase 4]
Summary
A Phase 4 clinical trial evaluating Solum IV and bone marrow concentrate with growth factor concentrate in TLIF for degenerative spine conditions has been withd…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seton Healthcare Family | Conditions: Degenerative Disc Disease, Isthmic-lytic Spondylolisthesis | Phase 4 | Status: WITHDRAWN